Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D’Ambrosio, S. Fagiuoli, Sergio Lazzaroni et al.|Journal of Hepatology|2018Cited by 132
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Laura Comi, Domenico Pontillo et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 7
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO RegistryFilippo Lagi, Michele Bellomo, Riccardo Lolatto et al.|Viruses|2025Cited by 1